Global Angioplasty Peripheral Drug Eluting Balloon Market was valued at USD 0.6 Billion in 2022 and is projected to reach USD 1.1 Billion by 2030, growing at a CAGR of 8.2% from 2024 to 2030.
The Global angioplasty peripheral drug-eluting balloon (DEB) market has been experiencing substantial growth due to increasing cases of peripheral artery diseases (PAD) and advancements in medical technologies. The rising prevalence of lifestyle-related diseases, such as diabetes and hypertension, has contributed to the growth in the demand for angioplasty procedures. The market is also benefiting from the shift towards minimally invasive procedures that offer faster recovery times and reduced risk of complications. As the healthcare sector continues to prioritize effective treatments for PAD, the drug-eluting balloon market is set to expand further. The use of DEBs, which provide localized drug delivery to prevent restenosis, is expected to replace traditional methods like bare-metal stents and balloon angioplasty in many cases, thereby driving the market's growth. The adoption of these devices in both developed and emerging economies is expected to fuel further market expansion.
The market is also witnessing significant trends such as the development of more advanced drug-eluting balloons with improved drug formulations, balloon coatings, and delivery mechanisms. These innovations aim to enhance clinical outcomes and improve patient safety. Moreover, the increasing preference for outpatient surgeries and the growing number of healthcare facilities investing in modern equipment are propelling the market. Additionally, regulatory approvals for newer devices are expected to further enhance market growth. The rising awareness about peripheral artery diseases and the growing geriatric population are expected to provide lucrative opportunities for industry players. Collaborations and partnerships among medical device manufacturers and healthcare providers are also likely to boost market expansion. As demand for effective, cost-efficient treatments grows, the angioplasty peripheral drug-eluting balloon market is poised for significant advancements in the coming years.
Get an In-Depth Research Analysis of the Gloabl Angioplasty Peripheral Drug Eluting Balloon Market Size And Forecast [2025-2032]
Nipro Corporation
Lifetech Scientific (Shenzhen) Co. Ltd
Eucatech AG
Bayer HealthCare AG
AngioCure
In
AVIDAL Vascular GmbH
Micell Technologies
Medtronic plc
NuVascular Technologies Inc
AnGes MG
Rontis AG
Contego Medical
QualiMed Innovative Medizinprodukte GmbH
Elixir Medical
QT Vascular Ltd
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Gloabl Angioplasty Peripheral Drug Eluting Balloon Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Gloabl Angioplasty Peripheral Drug Eluting Balloon Market
Paclitaxel-Eluting Balloons
Sirolimus-Eluting Balloons
Other Drug-Eluting Balloons
Peripheral Artery Disease (PAD)
Coronary Artery Disease (CAD)
Others
Hospitals
Ambulatory Surgical Centers
Cardiology Clinics
Direct Sales
Online Sales
Distributors/Wholesalers
Polymer-based Balloons
Silver-coated Balloons
Bioresorbable Balloons
US (Global, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Angioplasty Peripheral Drug Eluting Balloon Market Research Analysis
1. Introduction of the Gloabl Angioplasty Peripheral Drug Eluting Balloon Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Gloabl Angioplasty Peripheral Drug Eluting Balloon Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Gloabl Angioplasty Peripheral Drug Eluting Balloon Market, By Type
6. Gloabl Angioplasty Peripheral Drug Eluting Balloon Market, By Application
7. Gloabl Angioplasty Peripheral Drug Eluting Balloon Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. Gloabl Angioplasty Peripheral Drug Eluting Balloon Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/